AlphaYou
Overview
Smart money at a glance
Filings to Oct 7, 2026Net selling: insiders sold $86M and bought $0 on the open market in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- -$86M netNet selling
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, quarter ended Jun 30, 2026
- 8 added, 1 cutMore adding
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 7- 52-wk high
- $100.36
- 52-wk low
- $30.08
- Prev close
- $98.35
- Mkt cap
- $7.94B
- P/E
- 32.5x
- Fwd P/E
- 33.0x
- P/S
- 11.0x
- P/B
- 21.6x
- Profit margin
- +15.1%
- Op margin
- +19.0%
- ROE
- +30.4%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsQuestions about HNGE filings
Are insiders buying or selling Hinge Health, Inc. (HNGE) stock?
Net selling: insiders sold $86M and bought $0 of HNGE stock on the open market in the 90 days to Oct 7, 2026, according to SEC Form 4 filings. $85.9M of the sales were made under pre-set Rule 10b5-1 trading plans. The largest was Mecklenburg, Gabriel M.I. (Director), who sold $36.2M. The latest filing was on Sep 23, 2026.
Which members of Congress have traded HNGE recently?
None. No member of Congress disclosed a HNGE trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this HNGE smart-money data?
This summary uses filings available on Oct 7, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
8 funds hold a position and insiders have been net selling.
What funds are doing
Buys/Adds (3)
- TS
Two Sigma
$135.3M
added
- OB
Oberweis
$53.0M
added
- AF
Alta Fox
$22.6M
bought
What insiders are doing
How top traders are positioned
No tracked top-trader positions in HNGE right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Earnings came in 135.7% above what analysts expected.
Last report
Aug 4, 2026
Period ending
Jun 30, 2026
Earnings per share
$0.28 expected
Revenue
No reported revenue on record
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Jun 30, 2026 | Aug 4, 2026 | $0.66 / $0.28Alpha Vantage | +135.71% beat | Unavailable | Unavailable |
| Mar 31, 2026 | May 5, 2026 | $0.45 / $0.40Alpha Vantage | +12.50% beat | Unavailable | Unavailable |
| Dec 31, 2025 | Feb 10, 2026 | $0.49 / $0.43Alpha Vantage | +13.95% beat | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 4, 2025 | $0.44 / $0.24Alpha Vantage | +83.33% beat | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 5, 2025 | $0.70 / $0.09Alpha Vantage | +$0.61 beat | Unavailable | Unavailable |
| Mar 31, 2025 | May 5, 2025 | Unavailable | - | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 3, 2026, in 27 days
Estimates as of Oct 6, 2026
EPS expected
$0.57 to $0.69
Revenue expected
14 analysts
Last 30 days
Analysts cutting estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $154.2M | $170.7M | $182.3M | $212.8M |
| Cost of what it sold | $28.0M | $26.6M | $28.1M | $28.9M |
| Gross profit | $126.2M | $144.2M | $154.2M | $183.9M |
| What it spent | ||||
| Research and development | $31.9M | $32.8M | $30.3M | $34.1M |
| Sales and admin | $36.9M | $24.4M | $23.0M | $28.0M |
| Other operating costs | $63.6M | $59.8M | $68.8M | $81.4M |
| Total operating expenses | $132.3M | $116.9M | $122.2M | $143.5M |
| What was left | ||||
| Operating profit | -$6.1M | $27.3M | $32.1M | $40.4M |
| Profit before tax | -$1.6M | $32.2M | $35.9M | $44.4M |
| Tax | $206.0K | $122.0K | $814.0K | $740.0K |
| Net profit | -$1.8M | $32.1M | $35.1M | $43.7M |
| EBITDA | -$5.5M | $29.7M | $33.2M | $45.5M |
Technicals
Price structure
This stock is in a strong uptrend.
Trend
Strong uptrend
100 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage leans bearish
CFO James Budge relinquished 4,614 Hinge Health (HNGE) shares at $97.24 each for tax withholding.
NeutralOct 1After selling 49,064 shares, a 10% holder proposes another Hinge Health (HNGE) share sale.
NeutralOct 1After six sales, a 10% holder proposes another share sale at Hinge Health (HNGE).
Leans bearishOct 1A 10% stockholder plans a Hinge Health (HNGE) share sale through Raymond James.
NeutralOct 1A 10% stockholder proposes selling Hinge Health (HNGE) shares after six prior sales.
Leans bearishSep 30Hinge Health stock hits all-time high at 97.72 USD By Investing.com
NeutralSep 29Hinge Health stock hits all-time high at 97.72 USD
BullishSep 29ETFs Investing in Hinge Health, Inc. Class A Stocks
NeutralSep 27